News

FILTER BY:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Medical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared HolzMedical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared Holz
News

Medical device companies ‘clear beneficiary’ following Humana’s warning, says Mizuho’s Jared Holz

January 19, 2024
Bitcoin ETFs not good for Coinbase: Mizuho's DolevBitcoin ETFs not good for Coinbase: Mizuho's Dolev
News

Bitcoin ETFs not good for Coinbase: Mizuho's Dolev

January 13, 2024
Price compression of bitcoin trading begins today, says Mizuho’s Dan DolevPrice compression of bitcoin trading begins today, says Mizuho’s Dan Dolev
News

Price compression of bitcoin trading begins today, says Mizuho’s Dan Dolev

January 12, 2024
Eli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared HolzEli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared Holz
News

Eli Lilly’s DTC obesity drug push ‘not necessarily an industry game changer’: Mizuho’s Jared Holz

January 5, 2024
Mizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentallyMizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentally
News

Mizuho’s Holz on weight loss drugs: Lilly and Novo Nordisk are in excellent shape fundamentally

January 4, 2024
Mizuho Americas hires Bill Featherston as managing director and head of researchMizuho Americas hires Bill Featherston as managing director and head of research
Press Release

Mizuho Americas hires Bill Featherston as managing director and head of research

January 3, 2024
Obesity drug enthusiasm can continue in 2024: Mizuho’s Jared HolzObesity drug enthusiasm can continue in 2024: Mizuho’s Jared Holz
News

Obesity drug enthusiasm can continue in 2024: Mizuho’s Jared Holz

December 28, 2023
Mizuho’s Dan Dolev sees more upside for Affirm and SoFi in 2024Mizuho’s Dan Dolev sees more upside for Affirm and SoFi in 2024
News

Mizuho’s Dan Dolev sees more upside for Affirm and SoFi in 2024

December 27, 2023
Correction needed for some markets, Mizuho’s Ricchiuto saysCorrection needed for some markets, Mizuho’s Ricchiuto says
News

Correction needed for some markets, Mizuho’s Ricchiuto says

December 22, 2023
back-to-top-blue